Literature DB >> 33578741

EEG Data Quality: Determinants and Impact in a Multicenter Study of Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

Anna Kaiser1, Pascal-M Aggensteiner1, Martin Holtmann2, Andreas Fallgatter3, Marcel Romanos4, Karina Abenova1, Barbara Alm5, Katja Becker6,7, Manfred Döpfner8, Thomas Ethofer3, Christine M Freitag9, Julia Geissler4, Johannes Hebebrand10, Michael Huss11, Thomas Jans4, Lea Teresa Jendreizik8, Johanna Ketter6, Tanja Legenbauer2, Alexandra Philipsen12, Luise Poustka13, Tobias Renner14, Wolfgang Retz15,16, Michael Rösler16, Johannes Thome17, Henrik Uebel-von Sandersleben13, Elena von Wirth8, Toivo Zinnow16, Sarah Hohmann1, Sabina Millenet1, Nathalie E Holz1, Tobias Banaschewski1, Daniel Brandeis1,18,19,20.   

Abstract

Electroencephalography (EEG) represents a widely established method for assessing altered and typically developing brain function. However, systematic studies on EEG data quality, its correlates, and consequences are scarce. To address this research gap, the current study focused on the percentage of artifact-free segments after standard EEG pre-processing as a data quality index. We analyzed participant-related and methodological influences, and validity by replicating landmark EEG effects. Further, effects of data quality on spectral power analyses beyond participant-related characteristics were explored. EEG data from a multicenter ADHD-cohort (age range 6 to 45 years), and a non-ADHD school-age control group were analyzed (ntotal = 305). Resting-state data during eyes open, and eyes closed conditions, and task-related data during a cued Continuous Performance Task (CPT) were collected. After pre-processing, general linear models, and stepwise regression models were fitted to the data. We found that EEG data quality was strongly related to demographic characteristics, but not to methodological factors. We were able to replicate maturational, task, and ADHD effects reported in the EEG literature, establishing a link with EEG-landmark effects. Furthermore, we showed that poor data quality significantly increases spectral power beyond effects of maturation and symptom severity. Taken together, the current results indicate that with a careful design and systematic quality control, informative large-scale multicenter trials characterizing neurophysiological mechanisms in neurodevelopmental disorders across the lifespan are feasible. Nevertheless, results are restricted to the limitations reported. Future work will clarify predictive value.

Entities:  

Keywords:  artifacts; attention-deficit/hyperactivity disorder (ADHD); data quality; electroencephalography (EEG); multicenter study

Year:  2021        PMID: 33578741      PMCID: PMC7916500          DOI: 10.3390/brainsci11020214

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  44 in total

1.  EEG-BOLD correlations during (post-)adolescent brain maturation.

Authors:  Rafael Lüchinger; Lars Michels; Ernst Martin; Daniel Brandeis
Journal:  Neuroimage       Date:  2011-02-22       Impact factor: 6.556

2.  Electroencephalography.

Authors:  Andrea Biasiucci; Benedetta Franceschiello; Micah M Murray
Journal:  Curr Biol       Date:  2019-02-04       Impact factor: 10.834

3.  Age-related changes in quantitative EEG in attention-deficit/hyperactivity disorder.

Authors:  S M Bresnahan; J W Anderson; R J Barry
Journal:  Biol Psychiatry       Date:  1999-12-15       Impact factor: 13.382

4.  EEG differences between eyes-closed and eyes-open resting remain in healthy ageing.

Authors:  Robert J Barry; Frances M De Blasio
Journal:  Biol Psychol       Date:  2017-09-21       Impact factor: 3.251

5.  Applying dimension reduction to EEG data by Principal Component Analysis reduces the quality of its subsequent Independent Component decomposition.

Authors:  Fiorenzo Artoni; Arnaud Delorme; Scott Makeig
Journal:  Neuroimage       Date:  2018-03-09       Impact factor: 6.556

6.  Novel flexible Dry multipin electrodes for EEG: Signal quality and interfacial impedance of Ti and TiN coatings.

Authors:  P Fiedler; C Fonseca; P Pedrosa; A Martins; F Vaz; S Griebel; J Haueisen
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

7.  Association of Preterm Birth With Attention-Deficit/Hyperactivity Disorder-Like and Wider-Ranging Neurophysiological Impairments of Attention and Inhibition.

Authors:  Anna-Sophie Rommel; Sarah-Naomi James; Gráinne McLoughlin; Daniel Brandeis; Tobias Banaschewski; Philip Asherson; Jonna Kuntsi
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-10-24       Impact factor: 8.829

8.  Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife.

Authors:  Julia Geissler; Thomas Jans; Tobias Banaschewski; Katja Becker; Tobias Renner; Daniel Brandeis; Manfred Döpfner; Christina Dose; Christopher Hautmann; Martin Holtmann; Carolin Jenkner; Sabina Millenet; Marcel Romanos
Journal:  Trials       Date:  2018-04-27       Impact factor: 2.279

9.  Individualised stepwise adaptive treatment for 3-6-year-old preschool children impaired by attention-deficit/hyperactivity disorder (ESCApreschool): study protocol of an adaptive intervention study including two randomised controlled trials within the consortium ESCAlife.

Authors:  Katja Becker; Tobias Banaschewski; Daniel Brandeis; Christina Dose; Christopher Hautmann; Martin Holtmann; Thomas Jans; Lea Jendreizik; Carolin Jenkner; Katja John; Johanna Ketter; Sabina Millenet; Ursula Pauli-Pott; Tobias Renner; Marcel Romanos; Anne-Katrin Treier; Elena von Wirth; Anne-Kathrin Wermter; Manfred Döpfner
Journal:  Trials       Date:  2020-01-09       Impact factor: 2.279

10.  ESCAlate - Adaptive treatment approach for adolescents and adults with ADHD: study protocol for a randomized controlled trial.

Authors:  Toivo Zinnow; Tobias Banaschewski; Andreas J Fallgatter; Carolin Jenkner; Florence Philipp-Wiegmann; Alexandra Philipsen; Wolfgang Retz; Esther Sobanski; Johannes Thome; Michael Rösler
Journal:  Trials       Date:  2018-05-18       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.